Transcat, Inc (NASDAQ:TRNS) Files An 8-K Regulation FD DisclosureItem 7.01 Regulation FD Disclosure.
On December 20, 2017, Transcat, Inc. (the “Company”) issued a press release announcing that it has filed a registration statement on Form S-3. Once declared effective by the Securities and Exchange Commission, the Company may, from time to time in one or more future offerings, issue various types of securities, including common stock, warrants to purchase other securities, purchase contracts, and units up to an aggregate amount of $50,000,000. A copy of the press release is furnished as Exhibit 99.1 to this report.
The information furnished to this Item 7.01, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities under such section and shall not be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
TRANSCAT INC ExhibitEX-99.1 2 transcat3357121-ex991.htm TRANSCAT FILES UNIVERSAL SHELF REGISTRATION STATEMENT ON FORM S-3 Exhibit 99.1 NEWSRELEASE Transcat,…To view the full exhibit click here
About Transcat, Inc (NASDAQ:TRNS)
Transcat, Inc. is a provider of calibration and laboratory instrument services and a distributor of professional grade test, measurement and control instrumentation. The Company conducts its business through two segments: service (Service) and distribution (Distribution). Through the Service segment, the Company offers calibration, repair, inspection, analytical qualifications, preventative maintenance and other related services, a majority of which are processed through its asset management system, CalTrak (CalTrak). Through its Distribution segment, the Company markets, sells and rents national brand instruments to customers around the globe. The Company is focused on providing its services and products to the life science industries, which include pharmaceutical, biotechnology, medical device manufacturing and other Food and Drug Administration (FDA)-regulated businesses.
